Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biodesix, Inc.

Biodesix, Inc. (BDSX) Stock Overview

Explore Biodesix, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BDSX●NASDAQ
HealthcareMedical - Diagnostics & Research
$28.08
$2.69(10.59%)
U.S. Market opens in 7h 56m

Biodesix, Inc. (BDSX)

Meyka AI Score

Z

Key Financials

Market Cap228.5M
P/E Ratio-9.08
EPS (TTM)$-3.17
ROE-7.88%
Fundamental Analysis

AI Price Forecasts

1 Month$27.39
3 Months$29.77
1 Year Target$27.36

BDSX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Biodesix, Inc. (NASDAQ: BDSX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biodesix, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDSX on the NASDAQ shows an RSI of 65.53, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $27.36 for the NASDAQ listing.

Key metrics behind Biodesix, Inc.'s NASDAQ-traded stock include a P/E ratio of -9.08 and a market capitalization of 228.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDSX on the NASDAQ.

Price Performance (NASDAQ: BDSX)

1-Day Change
10.58%
5-Day Change
11.41%
1-Month Change
27.61%
3-Month Change
89.57%
6-Month Change
117.13%
Year-to-Date (YTD) Change
312.87%
1-Year Change
186.77%
3-Year Change
-15.44%
5-Year Change
-84.59%
All-Time (Max) Change
-89.04%

Contact Information

https://www.biodesix.com
303 417 0500
919 West Dillon Road, Louisville, CO, 80027

Company Facts

3,340 Employees
IPO DateOct 28, 2020
CountryUS
Actively Trading

Frequently Asked Questions